MedTrace Logo

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

NCT04403984 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2023-03-08

No results posted yet for this study

Summary

This is a translational study in patients with operated early breast cancer of Luminal A or Luminal B sub types.The Hellenic Cooperative Oncology Group (HeCOG) has designed an observational biomarker-driven study in patients with Luminal A or Luminal B breast cancer, with the aim to collect valuable biological material from these patients and investigate biomarkers with potential prognostic value.

Conditions

Sponsors & Collaborators

  • Hellenic Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • George Fountzilas, MD · Hellenic Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-24
Primary Completion
2020-12-21
Completion
2023-03-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04403984 on ClinicalTrials.gov